The critical role of tryptophan-116 in the catalytic cycle of dimethylsulfoxide reductase from Rhodobacter capsulatus  by Ridge, Justin P et al.
The critical role of tryptophan-116 in the catalytic cycle of
dimethylsulfoxide reductase from Rhodobacter capsulatus
Justin P. Ridgea, Kondo-Francois Aguey-Zinsoub, Paul V. Bernhardtb, Graeme R. Hansonc,
Alastair G. McEwana;
aCentre for Metals in Biology, School of Molecular and Microbial Sciences, University of Queensland, Brisbane, Qld. 4072, Australia
bDepartment of Chemistry, School of Molecular and Microbial Sciences, University of Queensland, Brisbane, Qld. 4072, Australia
cCentre for Magnetic Resonance, University of Queensland, Brisbane, Qld. 4072, Australia
Received 18 December 2003; revised 10 March 2004; accepted 10 March 2004
First published online 23 March 2004
Edited by Hans Eklund
Abstract In dimethylsulfoxide reductase of Rhodobacter cap-
sulatus tryptophan-116 forms a hydrogen bond with a single oxo
ligand bound to the molybdenum ion. Mutation of this residue to
phenylalanine a¡ected the UV/visible spectrum of the puri¢ed
MoVI form of dimethylsulfoxide reductase resulting in the loss
of the characteristic transition at 720 nm. Results of steady-
state kinetic analysis and electrochemical studies suggest that
tryptophan 116 plays a critical role in stabilizing the hexacoor-
dinate monooxo MoVI form of the enzyme and prevents the
formation of a dioxo pentacoordinate MoVI species, generated
as a consequence of the dissociation of one of the dithiolene
ligands of the molybdopterin cofactor from the Mo ion.
+ 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
The dimethylsulfoxide (DMSO) reductase family of molyb-
denum enzymes is one of four families of enzyme that contain
a form of pterin molybdenum cofactor (Moco) [1]. In all
enzymes of this superfamily a molybdenum atom coordinated
by one or two ene-dithiolate ligands is provided by an organic
component known as molybdopterin (MPT). A distinctive
feature of the DMSO reductase family of MPT-containing
enzymes is that the Mo is bound by four thiolate ligands
provided by molybdopterin guanine dinucleotide (MGD) moi-
eties [1,2]. Enzymes of the DMSO reductase family are thus
far limited to prokaryotes where they play an important role
in anaerobic respiration and lithotrophy [3].
The X-ray crystal structure of several members of the
DMSO reductase family has been determined. These include
periplasmic DMSO reductase [4^8], periplasmic nitrate reduc-
tase (NAP) [9], formate dehydrogenases (FDH-H and FDH-
N) [10,11], trimethylamine-N-oxide (TMAO) reductase [12]
and arsenite oxidase (ASO) [13]. The common protein struc-
tural features of these enzymes give no indication as to how
their speci¢c catalytic properties are determined. However, an
examination of the Mo active site does reveal some signi¢cant
di¡erences between enzymes of the DMSO reductase family.
In DMSO reductase and TMAO reductase a ¢fth ligand to
the Mo is provided by a serine side chain [4,12], while in NAP
it is a cysteine residue [9] and in FDH a selenocysteine residue
[10]. In ASO, there is no amino acid ligand to the Mo atom
[13]. In addition, a terminal oxygen ligand is coordinated to
the Mo ion (oxo, hydroxo or aqua) [4,6,9,10,12,13]. Since al-
most all Moco-containing enzymes catalyze an oxygen atom
transfer it seems likely that di¡erences in the Mo active sites
represent the tuning of their thermodynamic and structural
properties to allow distinct substrates to be used.
A further level of diversity in the DMSO reductase family
can be seen in the interaction between the Mo active site and
nearby amino acid residues which are not directly coordinated
to the Mo center. In the crystal structure of DMSO reductase
it has been observed that a tryptophan (residue 116) hydro-
gen-bonds to an oxo group coordinated to the Mo ion [5,6,8].
This tryptophan residue is conserved in TMAO reductase,
which is almost structurally identical to DMSO reductase
[12]. In DMSO reductase another amino acid side chain pro-
vided by Y114 is also located close to the Mo active site [8].
Although recent studies have indicated that this residue does
not H-bond to the Mo-oxo group [8] two recent studies have
shown that Y114 plays a role in de¢ning the substrate spec-
i¢city and kinetic parameters of DMSO reductase [14,15]. In
the present paper we report the characterization of a
W116CF mutant DMSO reductase from Rhodobacter capsu-
latus. This enabled us to investigate the e¡ect of the removal
of the hydrogen bonding interaction between the NO1 hydro-
gen of W116 and the Mo-oxo group.
2. Materials and methods
2.1. Mutagenesis and expression of DMSO reductase
The mutagenesis of the dorA gene encoding DMSO reductase (ac-
cession number U49506) in Rb. capsulatus was carried out essentially
as described in [15]. Brie£y, complementary primers were designed
against the dorA nucleotide sequence containing the appropriate
changes to introduce the W116F mutation (numbering follows [5],
accession no. 1DMS). The primers used were W116Ffwd, 5P-GGC-
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TCCTATGGCTTCAAAAGCCCCGGG-3P, and W116Frev, 5P-CCC-
GGGGCTTTTGAAGCCATAGGAGCC-3P. These primers were then
used to mutate the construct, pUCJRDor [15], using the Quikchange
XL site-directed mutagenesis kit (Stratagene) following the manufac-
turer’s protocol. The entire fragment of the dor operon contained in
pUCJRDor was then sequenced to ensure that no non-speci¢c muta-
tions had occurred. This fragment was then cloned into pJP5603 to
form the construct pJP5603W116F. This construct was then conju-
gated into the Rb. capsulatus strain 37b4vdorA as described previously
[15]. The expression of mutant DMSO reductase was con¢rmed by
Western blotting. The genomic DNA of clones expressing DMSO
reductase was screened as described previously to con¢rm the pres-
ence of the mutation [15]. One clone was then selected for further
study and named 37b4W116F.
2.2. Puri¢cation of W116F DMSO reductase
Strain 37b4W116F was grown under phototrophic condition in
RCV medium supplemented with the appropriate antibiotics until
the culture reached late log/early stationary phase. DMSO reductase
production was then induced with the addition of 15 mM DMSO and
growth for a further 12 h. DMSO reductase was then puri¢ed from
37b4W116F as described previously [15]. Purity of the sample was
con¢rmed by sodium dodecyl sulfate^polyacrylamide gel electropho-
resis analysis.
2.3. UV/visible spectroscopy and steady-state kinetic analysis
All UV/visible spectroscopy was carried out using a Hitachi U-3000
spectrophotometer. Steady-state kinetics of dithionite-reduced meth-
ylviologen (MV):DMSO oxidoreductase activity and PES-dependent
dimethylsul¢de (DMS):dichlorophenol indophenol (DCPIP) oxidore-
ductase activity were measured as described previously [16,17]. Deter-
mination of kcat and Km values were carried out in triplicate. Values
of kcat are expressed as moles of DCPIP or reduced MV consumed per
mole of enzyme per second giving units of s31.
2.4. Electrochemistry and electrode preparation
Electrochemical measurements were performed with a BAS100B/W
workstation employing a conventional three electrode system compris-
ing an edge plane pyrolytic graphite working, Pt wire counter and Ag/
AgCl reference electrodes. Experiments were performed at 25‡C with-
in a Belle Technology glovebox under an atmosphere of N2 (O2 con-
centration less than 2 ppm). The electrochemical cell volume was
approximately 500 Wl, and the solution pH was varied from 5 to 10
using the bu¡er mixture of Bis-Tris propane (10 mM) and 2-amino-2-
methylpropan-1-ol (10 mM), with 0.01 M NaCl as supporting electro-
lyte.
A clean working electrode surface was obtained by cleaving a ca.
1 Wm layer from the face of the electrode using a microtome followed
by sonication in distilled water. No abrasives were used. A surfactant
¢lm of the enzyme was prepared and adsorbed to the surface of the
electrode as described previously [18]. A solution of protein (10 Wl, 86
WM) was combined with a 15 Wl solution comprising didodecyldimeth-
ylammonium bromide (DDAB, 2 mM) and Tris bu¡er (50 WM). The
working electrode surface was coated with this mixture and then
allowed to dry for a few hours at 6‡C.
2.5. Determination of O280 and Mo content
For native DMSO reductase accurate determination of the concen-
tration of a solution of puri¢ed enzyme relied on the previously pub-
lished extinction coe⁄cient for the long-wavelength transition (O725 =
2 mM31 cm31). However, as described below the W116F mutant
DMSO reductase lacked this transition and therefore this could not
be used to determining the concentration of a solution of this form of
the enzyme. It was essential to determine accurately the concentration
of W116F DMSO reductase to allow the determination of accurate
kinetic data and Mo:DMSO reductase molar ratio. To achieve this
total amino acid analysis of a solution of W116F DMSO reductase
with a known OD280 was carried out. The resulting molar amount of
each amino acid in the sample was then used to calculate an extinction
coe⁄cient for W116F DMSO reductase of O280 = 223 mM31 cm31.
This coe⁄cient was used in all subsequent experiments to determine
the concentration of W116F DMSO reductase present. The Mo con-
tent of duplicate samples of the wild-type and W116F DMSO reduc-
tase was determined using inductively coupled plasma mass spectrom-




Fig. 1 shows a comparison of the UV/visible absorption
spectra of the resting MoVI forms of native and W116F
DMSO reductase between 300 nm and 800 nm. The most
striking feature of the spectrum of the W116F enzyme was
the absence of the long-wavelength transition which in the
native enzyme is centered at 720 nm. The two transitions
present in the spectrum of the native enzyme at 480 and 550
nm were still present in the spectrum of W116F DMSO re-
ductase (Fig. 1) but their intensity was increased. The elec-
tronic transition centered at 380 nm was more de¢ned in the
spectrum of the W116F DMSO reductase compared to the
native enzyme due in part to the deepening of the trough
centered at 350 nm in the mutant enzyme. Addition of
DMS to native DMSO reductase causes the formation of a
pink species with a characteristic spectrum [7]. This has been
shown to be a MoIV complex with DMSO bound [19]. Bray
and co-workers have also shown that addition of DMSO to
the resting native enzyme also causes a change in the spectrum
[20]. However, the addition of DMSO or DMS at concentra-
tions of up to 28 mM and 25 mM respectively caused no
appreciable changes in the spectrum of the W116F form of
DMSO reductase.
3.2. Mo content of W116F DMSO reductase
Observation of the loss of the long-wavelength transition in
the optical spectrum for the W116F DMSO reductase imme-
diately led to concern over the integrity of the active site and
whether the Mo atom had been lost. This seemed unlikely
because of the presence of absorption bands in the visible
region which almost certainly arise from ligand-to-metal
charge transfer. Native and W116F DMSO reductase samples
of known concentration were analyzed for Mo content. The
ratio of Mo/polypeptide in the W116F form of DMSO reduc-
tase was determined to be 0.66 while the ratio seen in the
native DMSO reductase was 0.57 (Table 1). These data
show that spectral di¡erences between the two forms of
DMSO reductase do not arise from a di¡erence in Mo con-
tent.
Fig. 1. UV/visible absorption spectra of ‘as prepared’ oxidized form
of native DMSO reductase (solid line) and puri¢ed W116F mutant
DMSO reductase (dotted line).
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3.3. Steady-state kinetic analysis
DMSO reductase activity was assayed using dithionite-re-
duced MV as electron donor. The results in Table 1 show that
the W116F form of DMSO reductase had a low kcat towards
both DMSO and TMAO, retaining approximately 17% and
8% respectively of the activity seen in the wild-type DMSO
reductase. The Km for DMSO in the W116F mutant DMSO
reductase was about three times higher than that seen for the
native enzyme. Interestingly, the Km of the W116F mutant
enzyme for TMAO was approximately half the value seen
for the native DMSO reductase. For both substrates the value
of kcat/Km was reduced for the W116F mutant when com-
pared to the native enzyme. It has been demonstrated that
reduced MV not only acts as an electron donor to DMSO
reductase but is also able to activate inactive forms of the
enzyme which di¡er in the structure of the Mo active site
compared to the native enzyme [20,21]. Thus, the use of di-
thionite-reduced MV can be misleading with respect to the
understanding of the relationship between active site structure
and catalysis. It has been suggested that the PES-dependent
DMS:DCPIP oxidoreductase activity of DMSO reductase is a
more accurate measure of a catalytically active form of the
enzyme [20]. The W116F form of DMSO reductase had no
measurable activity in this assay with either DMS or trimeth-
ylamine as substrates. Furthermore, turnover of the mutant
enzyme with dithionite-reduced MV and DMSO did not gen-
erate an enzyme with PES-dependent DMS:DCPIP oxidore-
ductase activity.
3.4. Electrochemical measurements
Cyclic voltammetry and square wave voltammetry were em-
ployed to determine the midpoint potentials of the Mo center
as well as their pH dependence. Well separated reversible
MoVI=V and MoV=IV responses were observed with the enzyme
immobilized within a DDAB surfactant ¢lm adsorbed onto an
edge plane pyrolytic graphite working electrode (Fig. 2a). The
apparent midpoint potentials for the W116F mutant have
been plotted in Fig. 2b (circles) as a function of pH, and
the corresponding potentials reported for the native enzyme
under identical conditions [18] are included for comparison
(triangles). In the W116F mutant, both the higher potential
MoVI=V couple and the MoV=IV couple were observed to be
pH-dependent, and the slope of each pro¢le is approximately
359 mV/pH unit. The MoVI=V couple of the native enzyme
exhibits a slight cathodic shift but shows similar pH depen-
dence. However, the MoV=IV couple of the native enzyme is
pH-independent, indicating a crucial role for the W116/F116
residues in the native and mutant enzymes during electron
transfer.
4. Discussion
It is now accepted that the active form DMSO reductase is
hexacoordinate with ligands provided by four thiolates from
the two MGD groups, a hydroxymethyl ligand from S147 and
a single oxo group [1,3]. This oxo group is equivalent to oxo-2
Table 1
Molybdenum content and steady-state kinetic parameters determined for the native and W116F DMSO reductase from Rb. capsulatus for the
substrates DMSO and TMAO
Mo contenta MV:DMSO oxidoreductase MV:TMAO oxidoreductase
(mole mole31) kcat (s31)b Km (WM)c kcat/Km (WM31 s31) kcat (s31) Km (WM) kcat/Km (WM31 s31)
Native 0.57 42.9W 0.6 9.7W 1.2 4.4W 0.7 134.5W 4.9 193.8W 9.8 0.7 W 0.1
W116F 0.66 7.0W 0.2 26.1W 3.1 0.3W 0.0d 11.3W 0.3 95.9W 11.0 0.1 W 0.0e
aMo content was determined by ICP-MS.
bkcat values are given to one decimal place and are the mean of three determinations in each case ( WS.E.M.).
cKm values are given to one decimal place and are derived from a non-linear ¢t of a plot of the average of three determinations at each sub-
strate concentration of [substrate] (mM) vs. velocity (s31) ( W S.E.M.).
dActual value 0.03.
eActual value 0.02.
Fig. 2. a: Cyclic voltammogram of the W116F mutant of DMSO
reductase at DDAB surfactant-modi¢ed edge plane pyrolytic graph-
ite working electrode. Scan rate is 50 mV/s. b: Plot of midpoint re-
dox potentials of the Mo center of DMSO reductase vs. pH.
MoVI=V couple, native enzyme, open triangles; W116F, open circles;
MoV=IV couple, native enzyme, closed triangles; W116F, closed
circles.
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identi¢ed by Bailey and co-workers as the oxo group that is
reactive towards DMS [7]. This oxo group is H-bonded to
W116 and so it might have been predicted that disruption
of this H-bonding would a¡ect catalysis. The results presented
herein showed that a W116F mutation caused a reduction in
kcat towards DMSO and TMAO. In contrast, the Km for
DMSO in the W116F mutant is not markedly a¡ected
(three-fold increase) and the Km for TMAO is in fact reduced.
These data would imply that W116 has an important role in
the catalytic cycle of DMSO reductase but does not greatly
in£uence the binding of the substrate. Recently, the equivalent
tryptophan residue in the closely related biotin sulfoxide re-
ductase (BSO) was mutated and analyzed [22]. A W90F mu-
tant of BSO also exhibited a much reduced kcat value towards
a range of substrates compared to native BSO but Km was not
greatly a¡ected.
Site-directed mutagenesis studies have demonstrated that
Y114 in DMSO reductase has a critical role in catalysis
[14,15]. It is notable that Y114 is absent from TMAO reduc-
tase [12], consistent with the view that this amino acid plays a
critical role in S^O bond breakage during catalysis but is not
essential for N^O bond cleavage. A Y114F mutation caused
small and subtle changes to the UV/visible spectrum of the
resting MoVI form of DMSO reductase [15]. As shown above
the e¡ect of a W116F mutation is much more dramatic. The
transitions seen in the visible region of the spectrum of the
DMSO reductase arise from ligand-to-metal charge transfer.
Therefore, these absorption bands will be highly sensitive to a
change in ligating atom as well as any changes to the symme-
try of the Mo site.
The plasticity of the Mo active site has been the subject of
extensive discussion [8,23,24]. Schindelin and co-workers have
observed that there is discrete disorder at the Mo active site in
the 1.3 AX crystal structure of DMSO reductase from Rb.
sphaeroides [8]. The structure may be interpreted as a super-
position of two distinct active sites : a hexacoordinate mono-
oxo structure and a pentacoordinate dioxo structure in which
one dithiolene group (from the Q-MGD) is outside the Mo
coordination sphere [8]. The crystal structures of a number of
inactive forms of DMSO reductase have also been described
[23,24]. One of these forms, known as DMSORmodH, is
formed by treatment of resting DMSO reductase with HEPES
bu¡er. This results in movement of the Mo such that the
thiolates of the Q-MGD are no longer within the Mo coordi-
nation sphere and results in the formation of a pentacoordi-
nate dioxo Mo site [23]. HEPES treatment resulted in bleach-
ing of the 720 nm absorption band in DMSO reductase and a
loss of other visible absorption bands in the visible region.
Based on a comparison of the spectrum of the W116F mutant
form of DMSO reductase with that of DMSORmodH we sug-
gest that the W116F mutant enzyme also has a pentacoordi-
nate dioxo Mo center. Another similarity between
DMSORmodH and the W116F mutant is low activity in the
back assay with DMS as electron donor. Indeed, the W116F
mutant has no PES-dependent DMS:DCPIP oxidoreductase
activity and is unable to form a complex with DMS. ‘Redox-
cycling’ of DMSORmodH with dithionite-reduced MV and
DMSO regenerated an active form of the enzyme which can
subsequently catalyze the back reaction with DMS as electron
donor [23]. In contrast, redox cycling of the W116F mutant
does not restore DMS:DCPIP oxidoreductase activity.
On the basis of the above observations we suggest that
presence of the side chain of Y114, a requirement for an
S-oxide reductase with a high a⁄nity for sulfoxides, creates
Fig. 3. Scheme showing proposed protonation reactions associated with electron transfer in native DMSO reductase and the W116F mutant en-
zyme.
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instability in the Mo active site of DMSO reductase since this
side chain can in principle also H-bond to a Mo-oxo group.
We suggest that the critical role of W116 in DMSO reductase
is to H-bond to this Mo-oxo group and prevent movement of
the Mo-oxo unit away from the coordinating dithiolene of the
Q-MGD in the resting MoVI enzyme. When no H-bonding
amino acid side chain is present (as in the W116F mutant)
then the enzyme is stabilized in the inactive pentacoordinate
dioxo form.
W116 also in£uences the reductive steps in the conversion
of MoVI to MoIV. A comparison of the electrochemistry of
native DMSO reductase [18] and the W116F mutant reveals
that in both enzymes, the MoVI=V couple exhibits a pH de-
pendence of 359 mV/pH unit, which is indicative of a single
electron/single proton transfer reaction. We have previously
assigned the site of protonation as the oxo ligand adjacent to
W116 [18]. The in£uence of the W116 residue on the MoV=IV
couple is profound. In native DMSO reductase, the MoV=IV
couple is pH-independent in the range 56 pH6 10, which is
consistent with reduction of the hydroxo-MoV form to the
hydroxo-MoIV analogue with no coupled proton transfer. In
the W116F mutant, a 359 mV/pH unit shift in the MoV=IV is
seen in the range 56 pH6 9, which may be assigned to a
second single electron/single proton transfer reaction resulting
in a fully reduced aqua complex.
These results may be rationalized by reference to the
scheme shown in Fig. 3. The pH independence of the
MoV=IV couple in native DMSO reductase suggests that
W116 remains H-bonded to the hydroxo ligand during both
electron transfer steps. The hydroxo ligand, whilst accepting
an H-bond from W116, is unable to concurrently accept a
proton upon reduction to the tetravalent state. In the
W116F mutant, the phenyl ring is unable to participate in
H-bonding with the oxo/hydroxo-molybdenum center. The
absence of an H-bonding interaction involving the terminal
oxygen ligand must enhance its basicity in all oxidation states
relative to the native enzyme. The small anodic shift in the
MoVI=V couple seen for the W116F mutant indicates that the
pentavalent state is being stabilized, or that the hexavalent
state is destabilized relative to the native enzyme. The latter
hypothesis is more likely given that the oxo-MoVI moiety in
the W116F mutant lacks the stabilizing in£uence of the W116
H-bond donor whereas the MoV moieties are each able to be
stabilized by protonation, as opposed to H-bond formation,
in the native and mutant enzymes. The Mo(V) electron para-
magnetic resonance (EPR) spectrum of molybdenum enzymes
is highly sensitive to changes in coordination number and
geometry of the Mo active site [25,26]. We note that mutation
of the W90 residue in BSO resulted in changes in the g-values
of the X-band EPR spectrum compared to native enzyme and
a shift from a rhombic signal-giving species to a near-axial
species [22]. Although the nature of these changes is di⁄cult
to interpret it will be interesting to investigate the EPR spec-
troscopic properties of the W116F mutant of DMSO reduc-
tase and compare it to the known signal-giving species asso-
ciated with native enzyme [24,27].
The variation in pH dependence of the MoV=IV couple
going from native to the W116F mutant enzyme again impli-
cates W116 in H-bonding with the terminal oxygen ligand. As
mentioned above, the H-bonding interaction presumed to re-
main in the native enzyme upon reduction to MoIV is absent
in the W116F mutant. Therefore, the hydroxo-MoV moiety is
able to accept a second proton upon reduction to the tetra-
valent state. The apparent break in the W116F mutant
MoV=IV pH pro¢le allows an estimate of the putative hy-
droxo/aqua-MoIV protonation constant (pKaW9), which is
evidently much lower (pKa6 5) in the native enzyme due to
the competing in£uence of the W116 H-bond donor.
In conclusion, our data indicate that W116 plays a pivotal
role in maintaining the structure of the Mo active site in
DMSO reductase. We are currently pursuing a crystal struc-
ture of the W116 mutant enzyme and, together with further
spectroscopic studies (e.g. Raman spectroscopy, EPR spec-
troscopy), this structural information will aid interpretation
of our electrochemical and kinetic data.
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